nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulpiride—Glyburide—type 2 diabetes mellitus	0.518	1	CrCtD
Sulpiride—Glyburide—Glimepiride—type 2 diabetes mellitus	0.0715	0.21	CrCrCtD
Sulpiride—Glyburide—Tolazamide—type 2 diabetes mellitus	0.0715	0.21	CrCrCtD
Sulpiride—Glyburide—Gliclazide—type 2 diabetes mellitus	0.0678	0.199	CrCrCtD
Sulpiride—Glyburide—Glipizide—type 2 diabetes mellitus	0.0678	0.199	CrCrCtD
Sulpiride—Glyburide—Chlorpropamide—type 2 diabetes mellitus	0.062	0.182	CrCrCtD
Sulpiride—BCHE—Ramipril—type 2 diabetes mellitus	0.0438	0.392	CbGbCtD
Sulpiride—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0429	0.384	CbGbCtD
Sulpiride—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0251	0.225	CbGbCtD
Sulpiride—Glyburide—CPT1A—type 2 diabetes mellitus	0.000622	0.375	CrCbGaD
Sulpiride—Glyburide—ABCC8—type 2 diabetes mellitus	0.000431	0.26	CrCbGaD
Sulpiride—Glyburide—KCNJ11—type 2 diabetes mellitus	0.000304	0.183	CrCbGaD
Sulpiride—Glyburide—ABCC2—type 2 diabetes mellitus	0.000164	0.0991	CrCbGaD
Sulpiride—Glyburide—CYP3A4—type 2 diabetes mellitus	7.26e-05	0.0438	CrCbGaD
Sulpiride—Glyburide—ALB—type 2 diabetes mellitus	6.33e-05	0.0382	CrCbGaD
Sulpiride—DRD3—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	7.33e-06	0.000261	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—GCG—type 2 diabetes mellitus	7.3e-06	0.00026	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	7.28e-06	0.00026	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CCKAR—type 2 diabetes mellitus	7.27e-06	0.000259	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—GHRL—type 2 diabetes mellitus	7.25e-06	0.000259	CbGpPWpGaD
Sulpiride—CA2—Metabolism—PPARG—type 2 diabetes mellitus	7.22e-06	0.000257	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	7.19e-06	0.000256	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—CALCA—type 2 diabetes mellitus	7.16e-06	0.000255	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—CCL2—type 2 diabetes mellitus	7.15e-06	0.000255	CbGpPWpGaD
Sulpiride—CA9—Metabolism—AGT—type 2 diabetes mellitus	7.13e-06	0.000254	CbGpPWpGaD
Sulpiride—CA2—Metabolism—INS—type 2 diabetes mellitus	7.08e-06	0.000252	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	7.01e-06	0.00025	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—EDN1—type 2 diabetes mellitus	7.01e-06	0.00025	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CALM1—type 2 diabetes mellitus	7.01e-06	0.00025	CbGpPWpGaD
Sulpiride—CA9—Metabolism—APOE—type 2 diabetes mellitus	6.98e-06	0.000249	CbGpPWpGaD
Sulpiride—CA9—Metabolism—APOA1—type 2 diabetes mellitus	6.9e-06	0.000246	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	6.9e-06	0.000246	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.88e-06	0.000245	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—SNAP25—type 2 diabetes mellitus	6.86e-06	0.000244	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PSMD6—type 2 diabetes mellitus	6.86e-06	0.000244	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—SREBF1—type 2 diabetes mellitus	6.86e-06	0.000244	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TLE4—type 2 diabetes mellitus	6.82e-06	0.000243	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—C3—type 2 diabetes mellitus	6.74e-06	0.00024	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CTGF—type 2 diabetes mellitus	6.73e-06	0.00024	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—HMGCR—type 2 diabetes mellitus	6.67e-06	0.000238	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	6.66e-06	0.000237	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—GCG—type 2 diabetes mellitus	6.63e-06	0.000237	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	6.58e-06	0.000235	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.58e-06	0.000235	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ADRB3—type 2 diabetes mellitus	6.57e-06	0.000234	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IAPP—type 2 diabetes mellitus	6.54e-06	0.000233	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—ADRA2A—type 2 diabetes mellitus	6.53e-06	0.000233	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	6.53e-06	0.000233	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—INSR—type 2 diabetes mellitus	6.5e-06	0.000232	CbGpPWpGaD
Sulpiride—CA2—Metabolism—ALB—type 2 diabetes mellitus	6.49e-06	0.000231	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—INS—type 2 diabetes mellitus	6.48e-06	0.000231	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—AGT—type 2 diabetes mellitus	6.41e-06	0.000228	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.39e-06	0.000228	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	6.38e-06	0.000228	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—CCL2—type 2 diabetes mellitus	6.38e-06	0.000227	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.35e-06	0.000227	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	6.34e-06	0.000226	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	6.3e-06	0.000224	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CYP2E1—type 2 diabetes mellitus	6.27e-06	0.000224	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—IGF1—type 2 diabetes mellitus	6.27e-06	0.000224	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—CCR5—type 2 diabetes mellitus	6.27e-06	0.000223	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—AVP—type 2 diabetes mellitus	6.21e-06	0.000221	CbGpPWpGaD
Sulpiride—CA2—Metabolism—NOS3—type 2 diabetes mellitus	6.21e-06	0.000221	CbGpPWpGaD
Sulpiride—CA2—Metabolism—PIK3R1—type 2 diabetes mellitus	6.21e-06	0.000221	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CYP1A2—type 2 diabetes mellitus	6.2e-06	0.000221	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—SLC2A1—type 2 diabetes mellitus	6.2e-06	0.000221	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—C3—type 2 diabetes mellitus	6.12e-06	0.000218	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—EDNRB—type 2 diabetes mellitus	6.08e-06	0.000217	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PPARG—type 2 diabetes mellitus	6.08e-06	0.000217	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CYP3A4—type 2 diabetes mellitus	6.05e-06	0.000216	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.02e-06	0.000215	CbGpPWpGaD
Sulpiride—CA9—Metabolism—INS—type 2 diabetes mellitus	5.97e-06	0.000213	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—SLC2A4—type 2 diabetes mellitus	5.94e-06	0.000212	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GCG—type 2 diabetes mellitus	5.94e-06	0.000212	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—IL6—type 2 diabetes mellitus	5.94e-06	0.000212	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	5.92e-06	0.000211	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	5.91e-06	0.000211	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.91e-06	0.000211	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.91e-06	0.000211	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	5.85e-06	0.000209	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.82e-06	0.000207	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	5.8e-06	0.000207	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	5.8e-06	0.000207	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.74e-06	0.000205	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.72e-06	0.000204	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.72e-06	0.000204	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	5.72e-06	0.000204	CbGpPWpGaD
Sulpiride—CA2—Metabolism—PTGS2—type 2 diabetes mellitus	5.68e-06	0.000202	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—RBP4—type 2 diabetes mellitus	5.65e-06	0.000202	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	5.65e-06	0.000202	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—AVP—type 2 diabetes mellitus	5.64e-06	0.000201	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	5.64e-06	0.000201	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.62e-06	0.0002	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	5.61e-06	0.0002	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.6e-06	0.0002	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.6e-06	0.0002	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	5.56e-06	0.000198	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.53e-06	0.000197	CbGpPWpGaD
Sulpiride—CA9—Metabolism—ALB—type 2 diabetes mellitus	5.47e-06	0.000195	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.38e-06	0.000192	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	5.36e-06	0.000191	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	5.28e-06	0.000188	CbGpPWpGaD
Sulpiride—CA9—Metabolism—NOS3—type 2 diabetes mellitus	5.23e-06	0.000187	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PIK3R1—type 2 diabetes mellitus	5.23e-06	0.000187	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.21e-06	0.000186	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	5.18e-06	0.000185	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—C3—type 2 diabetes mellitus	5.16e-06	0.000184	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.12e-06	0.000183	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GNB3—type 2 diabetes mellitus	5.12e-06	0.000183	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—GCG—type 2 diabetes mellitus	5.12e-06	0.000183	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.12e-06	0.000183	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—HMOX1—type 2 diabetes mellitus	5.1e-06	0.000182	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	5.1e-06	0.000182	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	5.04e-06	0.00018	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.04e-06	0.00018	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CAT—type 2 diabetes mellitus	5.03e-06	0.000179	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5.02e-06	0.000179	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IAPP—type 2 diabetes mellitus	5.01e-06	0.000179	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—INSR—type 2 diabetes mellitus	4.98e-06	0.000177	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	4.9e-06	0.000175	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	4.89e-06	0.000174	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—APOB—type 2 diabetes mellitus	4.89e-06	0.000174	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	4.88e-06	0.000174	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	4.86e-06	0.000173	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	4.8e-06	0.000171	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.79e-06	0.000171	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PTGS2—type 2 diabetes mellitus	4.78e-06	0.000171	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GSTM1—type 2 diabetes mellitus	4.75e-06	0.000169	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.71e-06	0.000168	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.7e-06	0.000168	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—C3—type 2 diabetes mellitus	4.69e-06	0.000167	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—LPL—type 2 diabetes mellitus	4.66e-06	0.000166	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	4.65e-06	0.000166	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—ADCY5—type 2 diabetes mellitus	4.57e-06	0.000163	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GPX1—type 2 diabetes mellitus	4.55e-06	0.000162	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	4.53e-06	0.000162	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	4.52e-06	0.000161	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	4.52e-06	0.000161	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.45e-06	0.000159	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—AGT—type 2 diabetes mellitus	4.45e-06	0.000159	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CD36—type 2 diabetes mellitus	4.43e-06	0.000158	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.41e-06	0.000157	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	4.4e-06	0.000157	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	4.38e-06	0.000156	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PPP2CA—type 2 diabetes mellitus	4.38e-06	0.000156	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CYBA—type 2 diabetes mellitus	4.38e-06	0.000156	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—AVP—type 2 diabetes mellitus	4.35e-06	0.000155	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.35e-06	0.000155	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.33e-06	0.000155	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.32e-06	0.000154	CbGpPWpGaD
Sulpiride—CA6—Metabolism—AKT1—type 2 diabetes mellitus	4.31e-06	0.000154	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	4.3e-06	0.000153	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PLAT—type 2 diabetes mellitus	4.28e-06	0.000153	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—GHRL—type 2 diabetes mellitus	4.28e-06	0.000153	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.27e-06	0.000152	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CALCA—type 2 diabetes mellitus	4.23e-06	0.000151	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—APOB—type 2 diabetes mellitus	4.21e-06	0.00015	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—MTHFR—type 2 diabetes mellitus	4.2e-06	0.00015	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.19e-06	0.000149	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.14e-06	0.000148	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PPARA—type 2 diabetes mellitus	4.12e-06	0.000147	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	4.11e-06	0.000147	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—LPL—type 2 diabetes mellitus	4.02e-06	0.000143	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—AGT—type 2 diabetes mellitus	3.99e-06	0.000142	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	3.99e-06	0.000142	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.97e-06	0.000141	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.93e-06	0.00014	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CALM1—type 2 diabetes mellitus	3.92e-06	0.00014	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—GCG—type 2 diabetes mellitus	3.92e-06	0.00014	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.92e-06	0.00014	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—APOE—type 2 diabetes mellitus	3.91e-06	0.000139	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—APOA1—type 2 diabetes mellitus	3.87e-06	0.000138	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.85e-06	0.000137	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.84e-06	0.000137	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.77e-06	0.000134	CbGpPWpGaD
Sulpiride—CA12—Metabolism—AKT1—type 2 diabetes mellitus	3.73e-06	0.000133	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.7e-06	0.000132	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.67e-06	0.000131	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—C3—type 2 diabetes mellitus	3.62e-06	0.000129	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.6e-06	0.000128	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.6e-06	0.000128	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.45e-06	0.000123	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.44e-06	0.000123	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—AGT—type 2 diabetes mellitus	3.44e-06	0.000123	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.41e-06	0.000122	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PPARG—type 2 diabetes mellitus	3.41e-06	0.000121	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.38e-06	0.000121	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.38e-06	0.00012	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—LEP—type 2 diabetes mellitus	3.37e-06	0.00012	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—APOE—type 2 diabetes mellitus	3.37e-06	0.00012	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—INS—type 2 diabetes mellitus	3.34e-06	0.000119	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.33e-06	0.000119	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—AVP—type 2 diabetes mellitus	3.33e-06	0.000119	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.33e-06	0.000119	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.32e-06	0.000118	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.3e-06	0.000118	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.27e-06	0.000117	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—APOB—type 2 diabetes mellitus	3.22e-06	0.000115	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.21e-06	0.000114	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.18e-06	0.000113	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.17e-06	0.000113	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—LPL—type 2 diabetes mellitus	3.07e-06	0.00011	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—ALB—type 2 diabetes mellitus	3.06e-06	0.000109	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.01e-06	0.000107	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IRS1—type 2 diabetes mellitus	3e-06	0.000107	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—NOS3—type 2 diabetes mellitus	2.93e-06	0.000104	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PIK3R1—type 2 diabetes mellitus	2.93e-06	0.000104	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.88e-06	0.000103	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—INS—type 2 diabetes mellitus	2.88e-06	0.000103	CbGpPWpGaD
Sulpiride—CA2—Metabolism—AKT1—type 2 diabetes mellitus	2.85e-06	0.000102	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.83e-06	0.000101	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.83e-06	0.000101	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.78e-06	9.92e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.78e-06	9.92e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.77e-06	9.87e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—C3—type 2 diabetes mellitus	2.77e-06	9.87e-05	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PTGS2—type 2 diabetes mellitus	2.68e-06	9.55e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.64e-06	9.42e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.64e-06	9.41e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.63e-06	9.39e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—AGT—type 2 diabetes mellitus	2.63e-06	9.38e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.59e-06	9.22e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—LEP—type 2 diabetes mellitus	2.58e-06	9.19e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—APOE—type 2 diabetes mellitus	2.58e-06	9.19e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.55e-06	9.08e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.52e-06	9e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.52e-06	9e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.43e-06	8.67e-05	CbGpPWpGaD
Sulpiride—CA9—Metabolism—AKT1—type 2 diabetes mellitus	2.4e-06	8.57e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—RELA—type 2 diabetes mellitus	2.38e-06	8.47e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.3e-06	8.2e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	2.2e-06	7.85e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.17e-06	7.72e-05	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.16e-06	7.71e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.14e-06	7.64e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.13e-06	7.59e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.13e-06	7.59e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.13e-06	7.59e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.12e-06	7.56e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.02e-06	7.22e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.02e-06	7.21e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2e-06	7.14e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.96e-06	7e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.93e-06	6.88e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.93e-06	6.88e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.87e-06	6.66e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.82e-06	6.48e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.82e-06	6.48e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.67e-06	5.95e-05	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.65e-06	5.9e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.64e-06	5.85e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.64e-06	5.83e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.63e-06	5.81e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.55e-06	5.52e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.53e-06	5.47e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.5e-06	5.36e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.43e-06	5.09e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.39e-06	4.96e-05	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—AKT1—type 2 diabetes mellitus	1.35e-06	4.8e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.28e-06	4.55e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	1.26e-06	4.48e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.25e-06	4.46e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.16e-06	4.14e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	9.62e-07	3.43e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.88e-07	3.16e-05	CbGpPWpGaD
